Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0184 | 0.6354 | 0.9783 |
Trichomonas vaginalis | esterase, putative | 0.0042 | 0 | 0.5 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0187 | 0.6495 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0187 | 0.6495 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0107 | 0.2931 | 0.4514 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0187 | 0.6495 | 1 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0042 | 0 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.008 | 0.1707 | 0.2629 |
Loa Loa (eye worm) | hypothetical protein | 0.0187 | 0.6495 | 1 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0184 | 0.6354 | 0.9783 |
Echinococcus granulosus | 6 phosphofructo 2 kinase:fructose 2 | 0.0187 | 0.6495 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0042 | 0 | 0.5 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.0184 | 0.6354 | 0.9783 |
Brugia malayi | beta-lactamase family protein | 0.0042 | 0 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.011 | 0.3072 | 0.5 |
Brugia malayi | beta-lactamase | 0.0042 | 0 | 0.5 |
Toxoplasma gondii | ABC1 family protein | 0.0042 | 0 | 0.5 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0042 | 0 | 0.5 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.0187 | 0.6495 | 1 |
Giardia lamblia | Hypothetical protein | 0.011 | 0.3072 | 0.5 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0042 | 0 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.011 | 0.3072 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0187 | 0.6495 | 1 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0042 | 0 | 0.5 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0042 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0184 | 0.6354 | 0.9783 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-1-like protein | 0.008 | 0.1707 | 0.2629 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0184 | 0.6354 | 0.9783 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.008 | 0.1707 | 0.2629 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0042 | 0 | 0.5 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.008 | 0.1707 | 0.2629 |
Onchocerca volvulus | 0.0187 | 0.6495 | 1 | |
Mycobacterium leprae | conserved hypothetical protein | 0.0042 | 0 | 0.5 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.011 | 0.3072 | 0.5 |
Schistosoma mansoni | 6-phosphofructokinase | 0.0187 | 0.6495 | 1 |
Mycobacterium leprae | Probable lipase LipE | 0.0042 | 0 | 0.5 |
Brugia malayi | beta-lactamase family protein | 0.0042 | 0 | 0.5 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.011 | 0.3072 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 7 umol/L | Antiproliferative activity against human CCRF-CEM cells assessed as cell viability after 72 hrs by MTT assay | ChEMBL. | 24012378 |
IC50 (functional) | = 33.5 umol/L | Antiproliferative activity against human A549 cells assessed as cell viability after 72 hrs by MTT assay | ChEMBL. | 24012378 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 24012378 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.